MX2008000874A - Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina. - Google Patents

Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina.

Info

Publication number
MX2008000874A
MX2008000874A MX2008000874A MX2008000874A MX2008000874A MX 2008000874 A MX2008000874 A MX 2008000874A MX 2008000874 A MX2008000874 A MX 2008000874A MX 2008000874 A MX2008000874 A MX 2008000874A MX 2008000874 A MX2008000874 A MX 2008000874A
Authority
MX
Mexico
Prior art keywords
methods
receptor antagonists
compositions
endothelin receptor
emergency contraception
Prior art date
Application number
MX2008000874A
Other languages
English (en)
Inventor
Regine Sitruk-Ware
Indrani C Bagchi
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of MX2008000874A publication Critical patent/MX2008000874A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se exponen metodos y composiciones que contienen antagonistas del receptor de endotelina para la anticoncepcion de emergencia.
MX2008000874A 2005-07-19 2006-07-19 Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina. MX2008000874A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70045505P 2005-07-19 2005-07-19
PCT/US2006/028031 WO2007012006A1 (en) 2005-07-19 2006-07-19 Methods and compositions for emergency contraception using endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
MX2008000874A true MX2008000874A (es) 2008-04-04

Family

ID=37669144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008000874A MX2008000874A (es) 2005-07-19 2006-07-19 Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina.

Country Status (8)

Country Link
US (1) US8173593B2 (es)
EP (2) EP1906987B1 (es)
AT (1) ATE495752T1 (es)
CA (1) CA2615393C (es)
DE (1) DE602006019733D1 (es)
ES (2) ES2359513T3 (es)
MX (1) MX2008000874A (es)
WO (1) WO2007012006A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL74665C (es) 1949-04-07
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (es) 1953-11-19
GB804199A (en) 1955-12-22 1958-11-12 Midland Silicones Ltd Organosiloxane compositions
GB798669A (en) 1956-12-12 1958-07-23 Midland Silicones Ltd Improvements in or relating to organosiloxane elastomer foams
US2927907A (en) 1957-01-07 1960-03-08 Dow Corning Siloxane elastomers
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3035016A (en) 1959-03-16 1962-05-15 Dow Corning Acyloxy siloxanes and a method of using the
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3920805A (en) 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4155991A (en) 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US3991760A (en) 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4310510A (en) 1976-12-27 1982-01-12 Sherman Kenneth N Self administrable anti-fertility composition
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4250611A (en) 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
US4368186A (en) 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
US4596576A (en) 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US4585647A (en) 1984-11-19 1986-04-29 Basf Corporation Methods and compositions for intravaginal contraception
NL8500470A (nl) 1985-02-19 1986-09-16 Achel Homesteel Pvba Intravaginaal orgaan.
DE3765145D1 (de) 1986-03-12 1990-10-31 Euro Celtique Sa Empfaengnisverhuetende zusammensetzung.
US5284828A (en) 1990-05-14 1994-02-08 Fujisawa Pharmaceutical Co. Ltd. Peptide compound and its preparation
US5382569A (en) 1991-05-16 1995-01-17 Warner-Lambert Company Endotherlin antagonists
US5378715A (en) 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5550110A (en) 1992-04-22 1996-08-27 Warner-Lambert Company Endothelin Antagonists II
FI95768C (fi) 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5811416A (en) * 1994-06-06 1998-09-22 Board Of Regents The University Of Texas System Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
US6162927A (en) 1994-08-19 2000-12-19 Abbott Laboratories Endothelin antagonists
US5766681A (en) 1995-06-22 1998-06-16 Styro-Stop, Inc. Insulation barrier and a method of making an insulation barrier
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6207696B1 (en) 1998-09-15 2001-03-27 Cytos Pharamaceuticals, Llc Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
US6545048B1 (en) 1999-06-29 2003-04-08 California Institute Of Technology Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity
WO2003093322A2 (en) 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
JP2006508086A (ja) 2002-10-24 2006-03-09 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 固形腫瘍を予防および治療するための方法および組成物

Also Published As

Publication number Publication date
EP1906987B1 (en) 2011-01-19
ATE495752T1 (de) 2011-02-15
CA2615393C (en) 2011-09-20
US20090203591A1 (en) 2009-08-13
DE602006019733D1 (de) 2011-03-03
EP2246062A1 (en) 2010-11-03
EP2246062B1 (en) 2012-09-26
EP1906987A4 (en) 2009-01-28
EP1906987A1 (en) 2008-04-09
CA2615393A1 (en) 2007-01-25
WO2007012006A1 (en) 2007-01-25
ES2395922T3 (es) 2013-02-18
ES2359513T3 (es) 2011-05-24
US8173593B2 (en) 2012-05-08

Similar Documents

Publication Publication Date Title
HRP20181459T1 (hr) Humanizirani antagonisti anti-beta7 i njihove uporabe
HK1097768A1 (en) Modified pyrimidine glucocorticoid receptor modulators
SG144146A1 (en) Adenosine receptor agonists
SG150539A1 (en) Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
SG169353A1 (en) Tamper resistant dosage forms
IN2014CN03629A (es)
TW200605887A (en) Muscarinic acetylcholine receptor antagonists
HK1120442A1 (en) Novel opioid antagonists
UA97502C2 (ru) Кристаллическая твердая основа разагилина
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200727920A (en) New regimens for oral monophasic contraceptives
IL187192A0 (en) Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway
EP1782370A4 (en) PRODUCTION AND / OR DELIVERY OF LOCAL ADVERTISING, SUCH AS, FOR EXAMPLE, ADVERTISING FOR CALL FUNCTIONALITY FACILITIES
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
ECSP066486A (es) Antagonistas de receptores de acetilcolina muscarínicos ii
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
MX2008000874A (es) Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina.
SG144934A1 (en) C5a receptor antagonists
TW200638932A (en) CCI-779 polymorph and use thereof
MY162185A (en) Alumina particles and methods of making the same
PL380665A1 (pl) Farmaceutyczne kompozycje
MX2009012643A (es) Particulas de alumina y metodos para fabricar las mismas.
NO20091016L (no) Pyridooksazepin-progesteron reseptormodulatorer
TW200634019A (en) Thienoisoquinoline-phenylsulfonamides and their use as er-nfkb inhibitors
TW200635902A (en) Methods and formulations

Legal Events

Date Code Title Description
FG Grant or registration